捐赠者-接受者匹配,获得移植和移植后结果之间的关联
Rowena Lalji1,2,3, Ryan Gately1,3, Ross Francis2,3
1Centre for Kidney Disease Research, University of Queensland, Brisbane, QLD, Australia.
Transplantation direct
|October 10, 2025
概括
澳大利亚匹配度得分 (M-得分) 揭示了移植中的不平等. 较高的M分数,表明难以匹配人类白细胞抗原 (HLA),与移植可能性降低和更差的结果相关,突出显示系统差异.
科学领域:
- 免疫遗传学 免疫遗传学
- 移植免疫学 移植免疫学
- 卫生公平研究 卫生公平研究
背景情况:
- 已故捐赠者的脏分配算法在全球范围内优先考虑人类白细胞抗原 (HLA) 匹配.
- 这种优先级可能使具有较少常见HLA等位基因的移植候选人处于不利地位,可能会造成进入障碍.
研究的目的:
- 开发和验证澳大利亚匹配度评分 (M-score) 以评估基于HLA匹配概率的移植访问和结果.
- 评估M-score和脏移植等候名单结果之间的关联.
主要方法:
- 使用来自澳大利亚和新西兰透析和移植注册表 (2006-2023) 的完整HLA-A,HLA-B和HLA-DR数据计算M分数.
- 采用多变量考克斯回归来分析M分数四分位数与移植时间,移植损失和急性排斥之间的关联.
主要成果:
- 分析了来自14,836名接受者和7,708名捐赠者的数据;10,760名接受者有等候名单数据.
- 较高的M分数与非欧洲澳大利亚人的比例增加相关 (Q4: 60% vs Q1: 16%).
- 在最高M分数四分位数 (Q4) 中的患者的移植概率显著降低 (aHR0.56),移植损失 (aHR1.39) 和急性排斥 (aHR1.29) 的风险更高.
结论:
- M-score有效地识别了难以匹配的HLA配置文件的移植接受者.
- 较高的M分数与减少对已故捐赠者移植的机会以及更差的移植后结果有关.
- 这些发现强调了当前基于HLA的已故捐赠者分配算法中的重大不平等.
相关概念视频
Tissue Transplantation
907
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
907
Kidney Transplant I: Introduction
340
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
340
Bone Marrow Sampling and Transplants
881
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
881
Cell-mediated Immune Responses
83.5K
Overview
83.5K
Kidney Transplant II: Surgical Procedure
307
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
307
Blood Transfusion
2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K


